Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.
Takeshi NagasakaHideyuki MishimaAkira SawakiMototsugu ShimokawaMichio InukaiKatsunori ShinozakiHiroaki TaniokaJunichiro NasuTomohiro NishinaShoichi HazamaMasazumi OkajimaYoshiyuki YamaguchiPublished in: BMJ open (2016)
UMIN000015405, Pre-results.